ALSO READFujifilm launches 'Instax mini 9' camera at Rs 5,999 Fujifilm launches 'X-E3' mirrorless digital camera at Rs 70,999 Manmohan Singh slams demonetisation, says note ban and hasty GST rollout affected growth After note ban, GST dents India Inc profits and hurts revenue growth: Icra Note ban, GST to impact India's Rs 1 lakh cr wedding industry: Assocham
Japanese photography and imaging major Fujifilm is aiming for double-digit topline growth at Rs 1,100 crore this financial year buoyed by opportunities in small towns as they come out of the crippling impact of the last year's note-ban.
In the past five years, the company claims to have achieved 9 per cent year-on-year growth that substantiates its target to achieve double-digit growth this year.
Nishiyama said after a slump post-GST rollout, the business has now started picking up and is hopeful of a promising future.
"Our focus here is on developing strategic solutions in medical systems, photo imaging, imaging capturing and graphic arts divisions," he said.
Fujifilm Sericol India, a group company based in Pune is developing inks for wide format printers.
"We already have local partners and are exploring the possibility of developing more products in association with local collaborators, Nishiyama said.
"With the launch of the Uvistar Hybrid 320, we aim to strengthen our presence in the graphic arts market here, which is one of the most important drivers of our growth in this market," he said.
The company is also betting big on growing medical devices market with 15-20 per cent growth.
Nishiyama pointed out that Fujifilm's medical business in India is driven by computer radiology and digital radiology products, which facilitate the digitization of X-rays.
"Currently we have 50 per cent market share for our CR systems and X-Ray films with over 25,000 installations across the country and 40 per cent market share for our DR systems with 400 installations, he added.